Skip to main content
Kudos

Explore subjects

All stories
  • Arts and humanities
  • Business and management
  • Environmental research
  • Life sciences
  • Medical research
  • Physical sciences
  • Social sciences
  • Technology and engineering
  • About Kudos

  • Publishers
  • Pharma
  • Institutions and universities
  • Individual researchers and groups

  • Welcome pack and guides
  • Webinars and courses
  • Blog and news

  • Search Kudos

    Main menu

  • Home
  • Showcases on Kudos

  • What's new
  • Support
  • Log in
  • Sign up free
  • Discover

  • Showcases on Kudos
  • Subjects on Kudos

  • Arts and humanities
  • Business and management
  • Environmental research
  • Life sciences
  • Medical research
  • Physical sciences
  • Social sciences
  • Technology and engineering
  • Services and resources

  • About Kudos

  • Publishers
  • Pharma
  • Institutions and universities
  • Individual researchers and groups

  • Welcome pack and guides
  • Webinars and courses
  • Blog and news
  • Admin

    Log in Sign up free
    niels steen krogh's profile pictureNK

    niels steen krogh

    4 Stories

    ZiteLab ApS

    ZiteLab ApS

    All Stories

    1. Comparing patient-reported outcomes entered at home versus at hospital, and testing touch screens for initial recruitment to scientific trials in arthritis patients

      Article • Scandinavian Journal of Rheumatology, November 2018, Taylor & Francis

      niels steen krogh

    2. Anti-cyclic citrullinated peptide antibodies, 28-joint Disease Activity Score, and magnetic resonance imaging bone oedema at baseline predict 11 years’ functional and radiographic outcome in early rheumatoid arthritis

      Article • Scandinavian Journal of Rheumatology, August 2018, Taylor & Francis

      niels steen krogh

    3. Biological treatment in ankylosing spondylitis in the Nordic countries during 2010–2016: a collaboration between five biological registries

      Article • Scandinavian Journal of Rheumatology, August 2018, Taylor & Francis

      Minna Törmänen, niels steen krogh

    4. Low starting dosage of infliximab with possible escalating dosage in psoriatic arthritis gives the same treatment results as standard dosage of adalimumab or etanercept: results from the nationwide Icelandic ICEBIO registry

      Article • Psoriasis Targets and Therapy, May 2018, Dove Medical Press

      niels steen krogh

    Kudos
    • For researchers
    • For publishers
    • For universities
    • For pharma
    • For research groups
    • Research showcase
    • About Kudos
    • News
    • Careers
    • Engineering blog
    • Service status
    • User guide
    • Content and resources
    • FAQs
    • Contact us
    • Terms & conditions
    • Privacy policy
    • Cookie policy

    © 2026 Kudos Innovations Ltd. Kudos is registered in England – Registration No. 08642156. Registered Office: Kudos Innovations Ltd, 100 Liverpool Street, London, EC2M 2AT, UK